Code
01N00317
Duration
01 January 2017 → 31 October 2021
Funding
Regional and community funding: Special Research Fund
Promotor
Research disciplines
-
Medical and health sciences
- Laboratory medicine
- Palliative care and end-of-life care
- Regenerative medicine
- Other basic sciences
- Laboratory medicine
- Palliative care and end-of-life care
- Regenerative medicine
- Other clinical sciences
- Other health sciences
- Nursing
- Other paramedical sciences
- Laboratory medicine
- Palliative care and end-of-life care
- Regenerative medicine
- Other translational sciences
- Other medical and health sciences
Keywords
Circulating cell-free DNA
Circulating tumor DNA
Liquid biopsy
Project description
The first step in the therapy of lung and hematological cancers is adequate diagnosis. Analysis of circulating tumor DNA by massively parallel sequencing is a non-invasive approach for early detection without a tissue biopsy. This approach is also promising for the development of a test for selection of cancer patients who could benefit from immunotherapy and precision medicine.